Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A van Es

Showing results (431-440 of 480) with videos related to

Pageof 48
Sort By:
Neurology|October 6, 2017
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trialsRuben P A van Eijk, Ashley R Jones, William Sproviero, et al.
Neurobiology of Aging|April 23, 2010
Polymorphisms in the GluR2 gene are not associated with amyotrophic lateral sclerosisElke Bogaert, An Goris, Philip Van Damme, et al.
Trials|December 5, 2022
Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trialSean W Willemse, Kit C B Roes, Philip Van Damme, et al.
Neurology|March 27, 2009
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALSA-M Wills, S Cronin, A Slowik, et al.
BMJ Neurology Open|February 23, 2026
Bi-allelic intermediate ATXN2 repeat expansions are associated with slow progressing, leg-onset familial ALSKoen Cedric Demaegd, Wouter Koole, Joke Jfa van Vugt, et al.
The Lancet. Neurology|September 11, 2007
ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association studyMichael A van Es, Paul W Van Vught, Hylke M Blauw, et al.
Iscience|May 1, 2026
Small RNA sequencing identifies serum tDR-1:34-Gly-GCC tiRNA levels as a biomarker for survival in amyotrophic lateral sclerosisKoen C Demaegd, Lindy Kool, Sharada Baindoor, et al.
JAMA Neurology|May 19, 2020
Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat ExpansionJoke De Vocht, Jeroen Blommaert, Martijn Devrome, et al.
Annals of Neurology|April 11, 2025
UNC13A Polymorphism Influences Survival in Patients with Frontotemporal DementiaLianne M Reus, Sean W Willemse, Sterre C M de Boer, et al.
Journal of Neurology|December 12, 2024
Diagnosing primary lateral sclerosis: a clinico-pathological studyEva M J de Boer, Bálint S de Vries, Wim Van Hecke, et al.
Pageof 48

Showing results (431-440 of 480) with videos related to

Sort By:
Pageof 48
Neurology|October 6, 2017
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trialsRuben P A van Eijk, Ashley R Jones, William Sproviero, et al.
Neurobiology of Aging|April 23, 2010
Polymorphisms in the GluR2 gene are not associated with amyotrophic lateral sclerosisElke Bogaert, An Goris, Philip Van Damme, et al.
Trials|December 5, 2022
Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trialSean W Willemse, Kit C B Roes, Philip Van Damme, et al.
Neurology|March 27, 2009
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALSA-M Wills, S Cronin, A Slowik, et al.
BMJ Neurology Open|February 23, 2026
Bi-allelic intermediate ATXN2 repeat expansions are associated with slow progressing, leg-onset familial ALSKoen Cedric Demaegd, Wouter Koole, Joke Jfa van Vugt, et al.
The Lancet. Neurology|September 11, 2007
ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association studyMichael A van Es, Paul W Van Vught, Hylke M Blauw, et al.
Iscience|May 1, 2026
Small RNA sequencing identifies serum tDR-1:34-Gly-GCC tiRNA levels as a biomarker for survival in amyotrophic lateral sclerosisKoen C Demaegd, Lindy Kool, Sharada Baindoor, et al.
JAMA Neurology|May 19, 2020
Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat ExpansionJoke De Vocht, Jeroen Blommaert, Martijn Devrome, et al.
Annals of Neurology|April 11, 2025
UNC13A Polymorphism Influences Survival in Patients with Frontotemporal DementiaLianne M Reus, Sean W Willemse, Sterre C M de Boer, et al.
Journal of Neurology|December 12, 2024
Diagnosing primary lateral sclerosis: a clinico-pathological studyEva M J de Boer, Bálint S de Vries, Wim Van Hecke, et al.
Pageof 48